Johnson & Johnson has announced plans to invest $55 billion in US manufacturing over the next four years, with a focus on research and technology investments. The move is part of a series of pledges by major American companies worth around $1 trillion aimed at expanding US manufacturing.
The company will break ground on a new facility in North Carolina to produce cancer medicines and has plans to build three more facilities and expand existing sites. CEO Joaquin Duato said the investment “will not only add U.S.-based jobs but manufacture cutting-edge medicines to treat patients in America and around the world”.
J&J already has significant manufacturing presence in the US, with a goal of demonstrating its commitment to President Trump’s trade war against China. The move is seen as an attempt to protect itself from potential tariffs on pharmaceuticals.
Other major companies such as Apple and Eli Lilly have also made similar announcements, including Apple’s $500 billion investment in the US over four years and Eli Lilly’s $27 billion plan to build manufacturing “mega-sites” in the US. These pledges are seen as a response to President Trump’s push to move manufacturing back to the US.
As the trade landscape continues to evolve, companies like Nvidia are shifting their supply chains away from Asia due to tariff threats. The latest developments highlight the ongoing efforts by major corporations to invest in US manufacturing and demonstrate their commitment to domestic production.
Source: https://www.axios.com/2025/03/21/johnson-johnson-55-billion-us-investment